Panagiotis Vagenas1, Lyuba Azbel1, Maxim Polonsky1, Nina Kerimi2, Mirlan Mamyrov2, Sergey Dvoryak3, Frederick L Altice1,4. 1. Yale School of Medicine, Section of Infectious Diseases, AIDS Program, New Haven, CT, USA. 2. United Nations Office on Drugs and Crime (UNODC), Regional Office for Central Asia, Tashkent, Uzbekistan. 3. Ukrainian Institute on Public Health Policy, Kyiv, Ukraine. 4. Yale School of Public Health, Department of Epidemiology of Microbial Diseases, New Haven, CT, USA.
Abstract
BACKGROUND: HIV incidence in Central Asia is rising rapidly. People who inject drugs (PWIDs) contribute greatest to the epidemic, with more than a quarter of all HIV cases being in the criminal justice system (CJS). This review assembled and aggregated recent data on drug-related health problems and respective healthcare services in the CJS of Central Asia and the Republic of Azerbaijan. METHODS: Online databases and published literature (peer-reviewed and gray) were reviewed. Additionally, prison officials in the 6 countries were invited to participate in a survey and prison administrators from Kazakhstan, Kyrgyzstan and Tajikistan completed it. RESULTS: The data on conditions and healthcare in Central Asian prisons are inconsistent and lack unbiased details. Reporting is primarily based on "official" disease registries, which markedly underestimate prevalence. Even these limited data, however, indicate that HIV prevalence and drug-related health problems are high, concentrated and, in some countries, rising rapidly in CJS. Only some of the range of HIV prevention interventions recommended by international organizations have been implemented in the region with two of the crucial interventions, needle and syringe exchange programs (NSP) and opioid substitution therapy (OST), only available in prisons in Kyrgyzstan, with Tajikistan implementing a pilot NSP and contemplating introduction of prison-based OST. CONCLUSIONS: Despite deficiencies in routine health reporting and insufficient HIV sentinel surveillance undertaken in prisons, the data available on the concentration of HIV within at-risk populations in prisons indicate a necessity to broaden the range and increase the scale the scale of HIV prevention and treatment services.
BACKGROUND: HIV incidence in Central Asia is rising rapidly. People who inject drugs (PWIDs) contribute greatest to the epidemic, with more than a quarter of all HIV cases being in the criminal justice system (CJS). This review assembled and aggregated recent data on drug-related health problems and respective healthcare services in the CJS of Central Asia and the Republic of Azerbaijan. METHODS: Online databases and published literature (peer-reviewed and gray) were reviewed. Additionally, prison officials in the 6 countries were invited to participate in a survey and prison administrators from Kazakhstan, Kyrgyzstan and Tajikistan completed it. RESULTS: The data on conditions and healthcare in Central Asian prisons are inconsistent and lack unbiased details. Reporting is primarily based on "official" disease registries, which markedly underestimate prevalence. Even these limited data, however, indicate that HIV prevalence and drug-related health problems are high, concentrated and, in some countries, rising rapidly in CJS. Only some of the range of HIV prevention interventions recommended by international organizations have been implemented in the region with two of the crucial interventions, needle and syringe exchange programs (NSP) and opioid substitution therapy (OST), only available in prisons in Kyrgyzstan, with Tajikistan implementing a pilot NSP and contemplating introduction of prison-based OST. CONCLUSIONS: Despite deficiencies in routine health reporting and insufficient HIV sentinel surveillance undertaken in prisons, the data available on the concentration of HIV within at-risk populations in prisons indicate a necessity to broaden the range and increase the scale the scale of HIV prevention and treatment services.
Authors: Olga Morozova; Lyuba Azbel; Yevgeny Grishaev; Sergii Dvoryak; Jeffrey A Wickersham; Frederick L Altice Journal: Int J Prison Health Date: 2013
Authors: Emma Jolley; Tim Rhodes; Lucy Platt; Vivian Hope; Alisher Latypov; Martin Donoghoe; David Wilson Journal: BMJ Open Date: 2012-10-18 Impact factor: 2.692
Authors: Duc Bui Nguyen; Nhan Thi Do; Ray W Shiraishi; Yen Ngoc Le; Quang Hong Tran; Hai Huu Nguyen; Nicholas Medland; Long Thanh Nguyen; Bruce Baird Struminger Journal: PLoS One Date: 2013-02-15 Impact factor: 3.240
Authors: Jacob M Izenberg; Chethan Bachireddy; Jeffrey A Wickersham; Michael Soule; Tetiana Kiriazova; Sergii Dvoriak; Frederick L Altice Journal: Int J Drug Policy Date: 2014-02-28
Authors: Lyuba Azbel; Jeffrey A Wickersham; Martin P Wegman; Maxim Polonsky; Murad Suleymanov; Rafik Ismayilov; Sergey Dvoryak; Signe Rotberga; Frederick L Altice Journal: Drug Alcohol Depend Date: 2015-03-19 Impact factor: 4.492
Authors: S Hermosilla; N El-Bassel; A Aifah; A Terlikbayeva; Z Zhumadilov; K Berikkhanova; M Darisheva; L Gilbert; N Schluger; S Galea Journal: Public Health Date: 2015-03-17 Impact factor: 2.427
Authors: Lyuba Azbel; Maxim Polonsky; Martin Wegman; Natalya Shumskaya; Ainura Kurmanalieva; Akylbek Asanov; Jeffrey A Wickersham; Sergii Dvoriak; Frederick L Altice Journal: Int J Drug Policy Date: 2016-06-11